Get started
Author

Brendan J. Chia

Observed names: Brendan Chia, Brendan J Chia, Brendan Joshua Chia, Brendan Sh Chia, Chia, Brendan Joshua
Institution: BC Cancer Agency
ORCID: 0009-0000-4337-7076
Observed ORCID: 0009-0000-4337-7076
OpenAlex ID: A5075011833
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer
2018 · John Conibear, Brendan Chia, et al. · BMJ Open · 77
PDF
Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al. · Cancer Epidemiology Biomarkers & Prevention · 5
Modeling Population-Level Impacts of Cell-Free DNA Screening for Colorectal Cancer in Canada
2025 · John M. Hutchinson, Yibing Ruan, et al. · JAMA Oncology · 3
Identifying the optimal post-surgical timing of molecular residual disease (MRD) detection in colorectal cancer (CRC) using an ultra-sensitive assay: Interim results from the VICTORI study.
2025 · Joao Paulo Solar Vasconcelos, Emma Titmuss, et al. · Journal of Clinical Oncology · 3
Molecular residual disease (MRD) detection using an ultra-sensitive assay in a prospective colorectal cancer cohort: The VICTORI study.
2026 · Joao Paulo Solar Vasconcelos, Emma Titmuss, et al. · Journal of Clinical Oncology · 2
A framework to evaluate surrogate endpoints at the trial level: analysis in colorectal cancer
2026 · Brendan J Chia, Carmen Allegra, et al. · JNCI Journal of the National Cancer Institute · 1
An asynchronous electronic consent for improving consent in research among patients with cancer
2025 · Brendan J Chia, Joao Paulo Solar Vasconcelos, et al. · The Oncologist · 1
PDF
Circulating tumor DNA (ctDNA) kinetics in colorectal cancer (CRC) treated with curative intent in the VICTORI study with an ultrasensitive MRD assay.
2024 · Joao Paulo Solar Vasconcelos, Emma Titmuss, et al. · Journal of Clinical Oncology · 1
A novel framework to grade the quality of surrogate endpoints at the trial level: An analysis of surrogate endpoints used in colorectal cancer trials.
2026 · Brendan Joshua Chia, Carmen Allegra, et al. · Journal of Clinical Oncology
PDF
Strategies to accelerate evidence generation and application in colorectal cancer care
2026 · Chia, Brendan Joshua · cIRcle (University of British Columbia)
PDF
Supplementary Methods from Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al.
PDF
Supplementary Table S7 from Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al.
Supplementary Table S1 from Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al.
Supplementary Table S3 from Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al.
Data from Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al.
Supplementary Table S2 from Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al.
Supplementary Table S4 from Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al.
Supplementary Table S5 from Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al.
Supplementary Table S8 from Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al.
Supplementary Table S6 from Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al.
Supplementary Figure S1 from Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy
2025 · Brendan J. Chia, Yibing Ruan, et al.
Abstract 3774: Detection of post-surgical minimal residual disease (MRD) in colorectal cancer; preliminary results from the VICTORI study
2025 · Emma Titmuss, Joao Paulo Solar Vasconcelos, et al. · Cancer Research
Impact of revising colorectal cancer screening guidelines on health care resources in Canada.
2024 · Brendan Chia, Yibing Ruan, et al. · Journal of Clinical Oncology
PDF
Comparative assessment of 111in-octreotide scintigraphy, 68GA-DOTATOC PET/CT and 18F-FDG PET/CT in the staging and management of neuroendocrine tumors (NETs)
2023 · Ali Zaidi, Brendan Chia, et al. · Endocrine Abstracts
Treatment Outcomes after Pulmonary Stereotactic Body Radiotherapy for Oligometastatic or Oligorecurrent Lung Lesions
2019 · Brendan Sh Chia · Annals of Oncology
Works count: 26
Citation count: 93
H-index: 3
I10-index: 1
Year
Topic
Type